Ractopamine hydrochloride

CAS : 90274-24-1

Ref. 3D-BR164308

Informations sur le produit

• Nom: Ractopamine hydrochloride
• Synonymes: 4-(3-{[2-Hydroxy-2-(4-Hydroxyphenyl)Ethyl]Amino}Butyl)Phenol Hydrochloride, 4-[3-[2-Hydroxy-2-(4-hydroxyphenyl)-ethyl]aminobutyl]phenol hydrochloride, Benzenemethanol, 4-hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)-, hydrochloride, Benzenemethanol, 4-hydroxy-α-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]-, hydrochloride, Benzenemethanol, 4-hydroxy-α-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]-, hydrochloride (1:1), El 737, Ly 031537, Ly O31537, Optaflexx, Paylean, Ractopamine Hcl, Topmax 9

Description

Ractopamine hydrochloride is a beta-agonist that stimulates the release of fatty acids from adipose tissue, increasing food intake and weight gain in pigs. It has been shown to have significant interactions with other drugs used for bowel disease, as well as with sodium carbonate, which can be used for control analysis. Ractopamine hydrochloride is an effective drug to stimulate the release of estradiol benzoate in rats during pregnancy. The matrix effect observed when analyzing samples containing ractopamine hydrochloride may be due to its ability to bind to serum proteins or lipids. This drug has been shown to have molecular docking properties that are similar to those found in other molecules.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 337.84 g/mol
• Formule: C₁₈H₂₃NO₃·HCl
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder